Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya
- PMID: 35603171
- PMCID: PMC9121796
- DOI: 10.3389/fimmu.2022.887213
Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya
Abstract
Introduction: Current diagnostic tools for schistosomiasis are limited, and new tests are necessary to enhance disease diagnosis and surveillance. Identification of novel disease-specific biomarkers may facilitate the development of such tests. We evaluated a panel of biomarkers used in sepsis and parasitic diseases for their potential suitability in the diagnosis of schistosomiasis.
Objective: The study evaluated the levels of systemic plasma biomarkers in relation to Schistosoma mansoni infection and parasite burden.
Methods: Six biomarkers were measured in the plasma of children from schistosomiasis-endemic regions using ELISA. The concentration of soluble CD23 (sCD23) and lipopolysaccharide (LPS) was tested in 199 and 124 plasma samples, respectively, while interleukin-6 (IL-6), soluble triggering receptor expressed on myeloid (sTREM) cells, eotaxin-1, and fatty acid-binding protein (FABP) concentrations were tested in 30 plasma samples.
Results: The concentration of IL-6, eotaxin-1, FABP, and LPS was similar between schistosome-infected and uninfected children. The schistosome-infected children had higher median levels of sTREM and sCD23 as compared to uninfected children, 119.0 (29.9-208.9) versus 10.7 (0.0-73.4) (p = 0.046) and 2,549.0 (1,899.0-3,356.0) vs. 2,035.0 (1,448.0-2,939.0) (p = 0.05), respectively. In addition, sTREM was positively correlated with egg density (p = 0.017).
Conclusion: Our data show that active schistosomiasis per se is associated with elevated levels of sTREM and sCD23. sTREM has potential diagnostic and prognostic values. However, these biomarkers did not distinguish between children with low egg burden and uninfected children.
Keywords: biomarkers; diagnosis; infection; intensity; schistosomiasis.
Copyright © 2022 Ondigo, Hamilton, Magomere, Onkanga, Mwinzi, Odiere and Ganley-Leal.
Conflict of interest statement
Authors RH and LG-L was employed by company Elegance Biotechnologies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Mulopo C, Chimbari MJ. Water, Sanitation, and Hygiene for Schistosomiasis Prevention: a Qualitative Analysis of Experiences of Stakeholders in Rural KwaZulu-Natal. J Water Sanitation Hygiene Dev (2021) 11(2):255–70. doi: 10.2166/WASHDEV.2021.182 - DOI
-
- WHO . Global Update on Implementation of Preventive Chemotherapy Against Neglected Tropical Diseases in 2018. Weekly epidemiological record No 38 (2019) 94:425–40.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
